Hepatotoxicity induced by arsenic trioxide: clinical features, mechanisms, preventive and potential therapeutic strategies
Frontiers in Pharmacology · 20.02.2025 · 16
DOI: 10.3389/fphar.2025.1536388 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.02.2025. Verfasst von Jun Wen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Cancer Center, The First Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Arsenic trioxide (ATO) has shown substantial efficacy in the treatment of patients with acute promyelocytic leukemia, and the utilization of ATO as a potential treatment for other tumors is currently being investigated; thus, its clinical application is becoming more widespread. However, the toxicity of ATO has prevented many patients from receiving this highly beneficial treatment. The clinical features, mechanisms, and preventive measures for ATO hepatotoxicity, as well as potential curative strategies, are discussed in this review. This review not only discusses existing drugs for the treatment of hepatotoxicity but also focuses on potential future therapeutic agents, providing forward-looking guidance for the clinical use of small molecule extracts, trace elements, antidiabetic drugs, and vitamins.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Haematology, Cancer Center, The First Hospital of Jilin University, Changchun, China.
- Center of Hematology, Peking University People's Hospital Qingdao, Qingdao, China.
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
Zitieren
APA
Wen, J., Li, A., Wang, Z., Guo, X., Zhang, G., Litzow, M. R., & Liu, Q. (2025). Hepatotoxicity induced by arsenic trioxide: clinical features, mechanisms, preventive and potential therapeutic strategies. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1536388
Vancouver
Wen J, Li A, Wang Z, Guo X, Zhang G, Litzow MR, et al. Hepatotoxicity induced by arsenic trioxide: clinical features, mechanisms, preventive and potential therapeutic strategies. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1536388
BibTeX
@article{Wen2025,
author = {Wen, Jun and Li, Aiwen and Wang, Ziliang and Guo, Xiaoxiao and Zhang, Gaoling and Litzow, Mark R and Liu, Qiuju},
title = {Hepatotoxicity induced by arsenic trioxide: clinical features, mechanisms, preventive and potential therapeutic strategies},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1536388}
}
EUVIMED